RxSight, Inc. increased earnings guidance for the full year 2024. For the year, the company expected revenue of $132.0 million to $137.0 million, representing implied growth of 48% to 54% compared to 2023, up from prior guidance of $128.0 million to $135.0 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
57.22 USD | -2.54% | -2.14% | +41.91% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.91% | 2.23B | |
-2.26% | 187B | |
+2.05% | 110B | |
-1.31% | 69.54B | |
+14.65% | 46.37B | |
-6.69% | 46.05B | |
+7.97% | 42.54B | |
+18.60% | 30.72B | |
+16.92% | 25.62B | |
-6.87% | 23.32B |
- Stock Market
- Equities
- RXST Stock
- News RxSight, Inc.
- RxSight, Inc. Increases Earnings Guidance for the Full Year 2024